A combination of flu, Covid, and respiratory viruses has created a miserable winter sickness cocktail with which the whole world can ring in the new year. That’s good news for drug companies slinging over-the-counter cold medicine, but bad news for…
Ah, nuts. They should’ve stuck to Baby Ruths and Butterfingers. Nestlé announced Tuesday it will unload the world’s only approved peanut allergy treatment just two years after acquiring the company that developed it. Potential patients must’ve found it easier to…
The fight against Alzheimer’s disease was dealt yet another setback on Monday. Two late-stage treatment studies conducted by Roche, which the pharma giant once hoped to be a miracle drug for more than 24 million people around the world, have…
How many doctors does it take to sell a medical practice network for billions of dollars? Apparently, at least a thousand. On Monday, Walgreens unit VillageMD agreed to acquire Summit Health, a physician’s group and parent company of CityMD urgent…
America’s biggest retailers are forking over $13.8 billion to shut down lawsuits accusing them of playing a role in the US opioid crisis. CVS, Walgreens, and Walmart have agreed to pay up in hopes of resolving lawsuits without admitting liability…
Biogen’s Alzheimer’s breakthrough is good news for just about everybody.
RSV is the latest respiratory disease on Pfizer’s radar.
You heard it right. On Tuesday, the Federal Drug Administration cleared the way for people with mild to moderate hearing loss to acquire hearing aids without a trip to a hearing specialist or a doctor’s prescription. An Audible Boom Hearing…
In his hit song “I Want a New Drug, Huey Lewis also made clear that it shouldn’t “cost too much.” Wait till he gets a load of this. As drugmakers roll out new treatments this year, they’re charging record-high prices,…
No one generates viral content quite like TikTok, but now its parent wants to try its hand at stopping viral infections. On Tuesday, China-based ByteDance announced it’s buying a chain of hospitals for $1.5 billion. It’s not the first tech…
